Spiriva Capsule
Product Images NDC 0597-0075

Product Visual Gallery

This gallery contains 29 technical images submitted to the FDA as part of the official labeling for Spiriva (NDC 0597-0075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Boehringer Ingelheim Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spiriva 01

Chemical structure diagram of tiotropium bromide, the active ingredient in Spiriva HandiHaler. The structure includes the molecular arrangement with nitrogen, oxygen, sulfur atoms, and bromide ion with water of hydration indicated.*

FDA Label Image

Spiriva 02

A line graph showing FEV1 (L) measured over 12 hours comparing SPIRIVA (n=202) and placebo (n=179). The graph plots FEV1 on the y-axis and time in hours on the x-axis, illustrating the difference in lung function between SPIRIVA and placebo groups during the study period.*

FDA Label Image

Spiriva 03

A line graph comparing FEV1 (L) over time in hours up to 12 hours between Spiriva HandiHaler (18 ug Tiotropium Bromide) and placebo groups. Spiriva group shows higher FEV1 values consistently compared to placebo over the 12-hour period.*

FDA Label Image

Spiriva 04

A line graph comparing FEV1 (L) over time (hours) for Spiriva and Ipratropium, showing FEV1 improvements from 0 to 6 hours. Spiriva data includes 153 subjects, Ipratropium data includes 72 subjects. The graph indicates FEV1 changes with distinct symbols for each treatment.*

FDA Label Image

Spiriva 05

A line graph comparing FEV1 (L) over time (hours) for Spiriva (n=153) and Ipratropium (n=72). Spiriva shows a higher and more sustained FEV1 increase compared to Ipratropium from 0 to 6 hours.*

FDA Label Image

Spiriva 06

A line graph comparing FEV1 (L) over 48 months between two groups: Tiotropium (n=2494) and Control (n=2363). The y-axis represents FEV1 in liters, ranging from approximately 1.00 to 1.30, while the x-axis represents time in months, from 0 to 48. The Tiotropium group shows higher FEV1 values throughout the period compared to the Control group.*

FDA Label Image

Spiriva 07

An instructional illustration showing a hand holding a capsule near an open mouth with a diagonal line crossing over them, indicating not to swallow the capsule orally. This is relevant to Spiriva HandiHaler 18 ug capsules intended for inhalation use rather than oral ingestion.*

FDA Label Image

Spiriva 08

FDA Label Image

Spiriva 09

An illustration depicting a person about to swallow a capsule, with a prohibition sign (a diagonal line) indicating that the capsule should not be taken orally by swallowing. The image visually instructs that the capsule is not for oral ingestion, consistent with inhalation use only instructions.*

FDA Label Image

Spiriva 10

An instructional diagram showing the parts of the Spiriva HandiHaler device, labeled with numbers 1 through 7. It depicts the HandiHaler capsule chamber and mouthpiece components held in a hand, illustrating how to open and use the device for inhaling Spiriva capsules.*

FDA Label Image

Spiriva 11

An instructional illustration showing hands peeling back individual Spiriva HandiHaler capsules from a blister pack strip. The capsules are labeled with Spiriva HandiHaler branding and dosage information, demonstrating how to access each capsule for oral inhalation use.*

FDA Label Image

Spiriva 12

An instructional diagram showing a Spiriva HandiHaler capsule marked TI 01 with an arrow pointing to the powder inside the capsule, labeled as the amount of powder in the Spiriva capsule.*

FDA Label Image

Spiriva 13

An instructional diagram showing a hand holding a Spiriva HandiHaler capsule device with the thumb pressing on a part of the device, indicated by a black arrow, demonstrating the device's use for oral respiratory inhalation.*

FDA Label Image

Spiriva 14

An instructional diagram showing a person's hands opening a Spiriva HandiHaler capsule inhaler device. One hand holds the device while the other hand lifts the inhaler lid upward, indicated by directional arrows.*

FDA Label Image

Spiriva 15

An instructional illustration showing hands opening a Spiriva HandiHaler device by squeezing and lifting the top part. The image demonstrates how to prepare the inhaler for capsule insertion by separating the capsule chamber.*

FDA Label Image

Spiriva 16

An instructional illustration showing hands peeling a strip of Spiriva HandiHaler capsules. The strip contains multiple individual labeled capsules of Spiriva HandiHaler 18 micrograms, used for oral inhalation. The image demonstrates the proper way to separate capsules from the strip for use.*

FDA Label Image

Spiriva 17

An instructional illustration showing a person peeling back a foil seal from a Spiriva HandiHaler capsule blister pack. Close-up views highlight the capsule packaging with label text including the product name Spiriva HandiHaler, and instructions to peel back the foil to access a single capsule for inhalation.*

FDA Label Image

Spiriva 18

An instructional illustration showing a hand holding a Spiriva HandiHaler inhaler device with its capsule chamber open. A capsule is depicted being dropped into the capsule chamber, indicated by a downward arrow, demonstrating how to place the medication capsule into the device for inhalation.*

FDA Label Image

Spiriva 19

Illustration showing how to place a capsule into the Spiriva HandiHaler device for inhalation. The image depicts a hand holding the mouthpiece open and inserting a single capsule into the chamber, indicated by an arrow pointing to the capsule.*

FDA Label Image

Spiriva 20

An illustration showing a hand holding a Spiriva HandiHaler device with an arrow indicating the direction to open or close part of the inhaler. This diagram likely demonstrates how to use the Spiriva HandiHaler for oral respiratory administration.*

FDA Label Image

Spiriva 21

An illustration showing a side profile of a person's mouth exhaling forcefully, indicated by an arrow pointing outward from the mouth, representing the action of blowing or inhaling medication. This image likely depicts a step in the use of an inhalation device such as the Spiriva HandiHaler capsule.*

FDA Label Image

Spiriva 22

An instructional diagram showing a person using the Spiriva HandiHaler device by placing the mouthpiece into their mouth and inhaling. The image highlights the inhalation process with an arrow indicating airflow into the mouth.*

FDA Label Image

Spiriva 23

An instructional illustration showing a side profile of a person's lower face exhaling or blowing out air, indicated by an arrow pointing outward from the mouth.*

FDA Label Image

Spiriva 24

An instructional illustration showing a person using a Spiriva HandiHaler capsule inhaler. The image depicts the hand holding the device close to the mouth, with an arrow indicating inhalation from the device.*

FDA Label Image

Spiriva 25

An instructional illustration showing a hand operating the Spiriva HandiHaler device, with arrows indicating a pressing or squeezing action. The image likely demonstrates how to open or activate the inhaler capsule holder for use.*

FDA Label Image

Spiriva 26

An instructional illustration showing a hand holding a round device, identified as the Spiriva HandiHaler, demonstrating the action of pressing a button or latch on the device, indicated by two black arrows pointing downwards at the bottom. The image is likely depicting part of the device's operation for capsule inhalation.*

FDA Label Image

Spiriva 27

An instructional diagram showing a hand holding a Spiriva HandiHaler device with a capsule inside. The hand is shown pressing down on the device with an arrow indicating the action, and a water tap icon above suggests rinsing or cleaning the device under running water.*

FDA Label Image

Spiriva 28

FDA Label Image

Spiriva 29

Packaging label for Spiriva HandiHaler 18 mcg/Capsule, containing tiotropium bromide inhalation powder. The package includes 30 capsules in 3 blister cards of 10 capsules each and is labeled for oral inhalation only using the HandiHaler device. Manufactured by Boehringer Ingelheim Pharmaceuticals, Inc., it features warnings not to swallow the capsules and instructions for proper storage and use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.